News

Agilent Technologies acquires lab instrument monitoring company Sigsense

Agilent Technologies, a provider of analytical and clinical laboratory technologies, announced it has acquired Sigsense, a company offering an AI-enabled monitoring system for lab instruments. 

Agilent provides labs in 110 countries with instruments, software, services and consumables to assist scientists in producing accurate results and economic, scientific and operational outcomes. 

Sigsense provides AI-enabled technology that allows labs to monitor instrument usage, condition and capacity in real time. The company’s sensors collect and interpret data into operational metrics for the instruments.

Sigsense’s tracking algorithm is already available to Agilent customers through its CrossLab Connect asset monitoring solution. CrossLab allows lab managers to see which technological assets are underperforming and how to optimize them. 

“We are excited to welcome the Sigsense team to Agilent. They are an innovator in leveraging artificial intelligence for lab operations,” Armin Jehle, vice president of Agilent CrossLab Services Division, said in a statement.

“By working closely as one team, we will extend their AI technology further, enabling more customers to gain more insights that contribute to reduced downtime and increased productivity.”  

THE LARGER TREND

Agilent Technologies is a publicly traded company headquartered in California, while Sigsense is a privately held company. 

Agilent went public on the New York Stock Exchange (A:NYSE) in 1999, trading for $27.20 per share. Its stock is currently $138.28 per share. The company’s stock dropped on Monday upon its announcement of the acquisition.

You may also like

News

Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused
News

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties